LEADER 03683nam 22006495 450 001 9910253895203321 005 20220816055915.0 010 $a3-319-41334-1 024 7 $a10.1007/978-3-319-41334-1 035 $a(CKB)3710000000873119 035 $a(DE-He213)978-3-319-41334-1 035 $a(MiAaPQ)EBC4697481 035 $a(PPN)19550769X 035 $a(EXLCZ)993710000000873119 100 $a20160926d2016 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAnti-inflammatory Nutraceuticals and Chronic Diseases /$fedited by Subash Chandra Gupta, Sahdeo Prasad, Bharat B. Aggarwal 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (VIII, 482 p. 61 illus., 35 illus. in color.) 225 1 $aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$v928 311 $a3-319-41332-5 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCurcuminand Its Role in Chronic Diseases -- Berberine and its Role in Chronic Disease -- Emodin and Its Role in Chronic Diseases -- Ursolic acid and chronic disease:  An overview of UA?s effects on prevention and treatment of obesity and cancer -- Tocotrienol and its Role in Chronic Diseases -- Indole-3-carbinol and its Role in Chronic Diseases -- Sanguinarine and its Role in Chronic Diseases -- Piperine and its Role in Chronic Diseases -- Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases -- Fisetin and its Role in Chronic Diseases. 330 $aThis comprehensive volume focuses on anti-inflammatory nutraceuticals and their role in various chronic diseases. Food and Drug Administration (FDA) approved drugs such as steroids, non-steroidal anti-inflammatory drugs (NSAIDS), statins and metformin have been shown to modulate inflammatory pathways, but their long-term intake has been associated with numerous side effects. This means that there is enormous potential for dietary agents that can modulate inflammatory pathways in humans. Leading experts describe the latest research on the role of anti-inflammatory nutraceuticals in preventing and treating chronic diseases. 410 0$aAdvances in Experimental Medicine and Biology,$x0065-2598 ;$v928 606 $aImmunology 606 $aFood$xBiotechnology 606 $aNutrition 606 $aPharmacology 606 $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000 606 $aFood Science$3https://scigraph.springernature.com/ontologies/product-market-codes/C15001 606 $aNutrition$3https://scigraph.springernature.com/ontologies/product-market-codes/C18000 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 615 0$aImmunology. 615 0$aFood$xBiotechnology. 615 0$aNutrition. 615 0$aPharmacology. 615 14$aImmunology. 615 24$aFood Science. 615 24$aNutrition. 615 24$aPharmacology/Toxicology. 676 $a615.854 702 $aGupta$b Subash Chandra$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPrasad$b Sahdeo$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAggarwal$b Bharat B$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910253895203321 996 $aAnti-inflammatory Nutraceuticals and Chronic Diseases$92532378 997 $aUNINA